» Articles » PMID: 10506625

Prognostic Significance of Occult Metastases Detected by Sentinel Lymphadenectomy and Reverse Transcriptase-polymerase Chain Reaction in Early-stage Melanoma Patients

Overview
Journal J Clin Oncol
Specialty Oncology
Date 1999 Oct 3
PMID 10506625
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Detection of micrometastases in the regional tumor-draining lymph nodes is critical for accurate staging and prognosis in melanoma patients. We hypothesized that a multiple-mRNA marker (MM) reverse transcriptase-polymerase chain reaction (RT-PCR) assay would improve the detection of occult metastases in the sentinel node (SN), compared with hematoxylin and eosin (H&E) staining and immunohistochemistry (IHC), and that MM expression is predictive of disease relapse.

Patients And Methods: Seventy-two consecutive patients with clinical early-stage melanoma underwent sentinel lymphadenectomy (SLND). Their SNs were serially sectioned and assessed for MAGE-3, MART-1, and tyrosinase mRNA expression by RT-PCR, in parallel with H&E staining and IHC, for melanoma metastases. MM expression in the SNs was correlated with H&E and IHC assay results, standard prognostic factors, and disease-free survival.

Results: In 17 patients with H&E- and/or IHC-positive SNs, 16 (94%) expressed two or more mRNA markers. Twenty (36%) of 55 patients with histopathologically negative SNs expressed two or more mRNA markers. By multivariate analysis, patients at increased risk of metastases to the SN had thicker lesions (P =.03), were 60 years of age or younger (P <.05), and/or were MM-positive (P <.001). Patients with histopathologically melanoma-free SNs who were MM-positive, compared with those who were positive for one or fewer mRNA markers, were at increased risk of recurrence (P =.02). Patients who were MM-positive with histopathologically proven metastases in the SN were at greatest risk of disease relapse (P =. 01).

Conclusion: H&E staining and IHC underestimate the true incidence of melanoma metastases. MM expression in the SN more accurately reflects melanoma micrometastases and is also a more powerful predictor of disease relapse than are H&E staining and IHC alone.

Citing Articles

Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma.

Zainulabadeen A, Yao P, Zare H PLoS One. 2017; 12(1):e0170025.

PMID: 28114321 PMC: 5256985. DOI: 10.1371/journal.pone.0170025.


Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Han D, Thomas D, Zager J, Pockaj B, White R, Leong S World J Clin Oncol. 2016; 7(2):174-88.

PMID: 27081640 PMC: 4826963. DOI: 10.5306/wjco.v7.i2.174.


Current status and scope of lymph node micrometastasis in gastric cancer.

Lee C, Park S, Kim J J Gastric Cancer. 2015; 15(1):1-9.

PMID: 25861517 PMC: 4389091. DOI: 10.5230/jgc.2015.15.1.1.


"Stealth" melanoma cells in histology-negative sentinel lymph nodes.

Itakura E, Huang R, Wen D, Cochran A Am J Surg Pathol. 2011; 35(11):1657-65.

PMID: 21997686 PMC: 3203732. DOI: 10.1097/PAS.0b013e3182322cf7.


Prognostic molecular biomarkers for cutaneous malignant melanoma.

Tanaka R, Koyanagi K, Narita N, Kuo C, Hoon D J Surg Oncol. 2011; 104(4):438-46.

PMID: 21557225 PMC: 3673884. DOI: 10.1002/jso.21969.